Discounted Cash Flow Rating
Buy
Return on Equity Rating
Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Wall Street Data Solutions Rating
Neutral
B
Astria Therapeutics, Inc. Common Stock (ATXS)
Pharmaceutical Preparations
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
75 STATE STREET, SUITE 1400
BOSTON, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/25/2015
Market Cap
628,013,589
Shares Outstanding
36,300,000
Weighted SO
41,034,797
Total Employees
N/A
Upcoming Earnings
08/05/2024
Beta
0.7350
Last Div
0.0000
Range
4.26-16.9
Chg
0.0600
Avg Vol
432108
Mkt Cap
628013589
Exch
NASDAQ
Country
US
Phone
617 349 1971
DCF Diff
5.3585
DCF
5.8215
Div Yield
0.0000
P/S
0.0000
EV Multiple
-5.9273
P/FV
1.8114
Div Yield %
0.0000
P/E
-6.7429
PEG
-0.2290
Payout
0.0000
Current Ratio
21.8652
Quick Ratio
21.8652
Cash Ratio
5.3382
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
-0.0001
ROA
-0.2534
ROE
-0.3265
ROCE
-0.2622
NI/EBT
1.0000
EBT/EBIT
1.0114
EBIT/Rev
0.0000
Debt Ratio
0.0157
D/E
0.0167
LT Debt/Cap
0.0129
Total Debt/Cap
0.0164
Int Coverage
-39.9952
CF/Debt
-13.8851
Equity Multi
1.0603
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-1.4230
FCF/Share
-1.4288
Cash/Share
6.2824
OCF/Sales
0.0000
FCF/OCF
1.0040
CF Coverage
-13.8851
ST Coverage
-64.5631
CapEx Coverage
-247.3262
Div&CapEx Cov
-247.3262
P/BV
1.8114
P/B
1.8114
P/S
0.0000
P/E
-6.7429
P/FCF
-7.7815
P/OCF
-7.8214
P/CF
-7.8214
PEG
-0.2290
P/S
0.0000
EV Multiple
-5.9273
P/FV
1.8114
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | X | X | X | X | X | 0.00 | 0.00 |
Cost Of Revenue | X | X | X | X | X | 0.00 | 0.00 |
Gross Profit | X | X | X | X | X | 0.00 | 0.00 |
Gross Profit Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Research And Development Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 11.67M | ▲ 15.73M |
General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 7.33M | ▲ 8.42M |
Selling And Marketing Expenses | X | X | X | X | X | 0.00 | 0.00 |
Selling General And Administrative Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ 7.33M | ▲ 8.42M |
Other Expenses | -XXXXXX | ▲ -XXXXX | ▲ -XXXX | ▼ -XXXXX | ▲ XXXX | ▼ -8.00K | ▼ -19.00K |
Operating Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ 19.00M | ▲ 24.15M |
Cost And Expenses | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ 19.00M | ▲ 24.15M |
Interest Income | XXXXXX | ▼ XXXXXX | ▼ XXXX | ▲ XXXXX | ▲ XXXXXXX | ▲ 2.80M | ▲ 4.24M |
Interest Expense | -XXXXXX | ▲ X | X | ▼ -XXXXX | ▼ -XXXXXXX | ▲ 2.31M | ▼ 0.00 |
Depreciation And Amortization | XXXX | ▼ XXXX | ▲ XXXX | ▲ XXXXXX | ▼ XXXXX | ▼ -15.20M | ▲ 43.28K |
Ebitda | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -19.00M | ▼ -24.15M |
Ebitda Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Operating Income | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -19.00M | ▼ -24.15M |
Operating Income Ratio | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | X.XXXXXXXXX | 0.00 | 0.00 |
Total Other Income Expenses Net | -XXXXXX | ▲ -XXXXX | ▲ -XXXX | ▼ -XXXXX | ▲ XXXXXXX | ▼ -12.41M | ▲ 4.22M |
Income Before Tax | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -31.41M | ▲ -19.93M |
Income Before Tax Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Income Tax Expense | -XXXXXX | ▲ -XXXXX | ▼ -XXXXX | ▼ -XXXXX | ▼ -XXXXXXX | ▲ 15.20K | ▼ -43.28K |
Net Income | -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -31.41M | ▲ -19.93M |
Net Income Ratio | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | X.XXXXXXXXXX | 0.00 | 0.00 |
Eps | -X.XX | ▲ -X.XX | ▲ -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -0.86 | ▲ -0.38 |
Eps Diluted | -X.XX | ▲ -X.XX | ▲ -X.XX | ▲ -X.XX | ▲ -X.XX | ▼ -0.86 | ▲ -0.38 |
Weighted Average Shs Out | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 36.52M | ▲ 52.29M |
Weighted Average Shs Out Dil | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 36.52M | ▲ 52.29M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | XXXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 175.69M | ▼ 172.18M |
Short Term Investments | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ 71.00M | ▲ 197.90M |
Cash And Short Term Investments | XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 246.69M | ▲ 370.07M |
Net Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Other Current Assets | XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXX | ▲ 4.25M | ▲ 4.45M |
Total Current Assets | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 250.94M | ▲ 374.52M |
Property Plant Equipment Net | XXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ 363.00K | ▼ 210.00K |
Goodwill | X | X | X | X | X | 0.00 | 0.00 |
Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Goodwill And Intangible Assets | X | X | X | X | X | 0.00 | 0.00 |
Long Term Investments | X | X | X | ▲ XXXXXXXX | ▼ X | 0.00 | 0.00 |
Tax Assets | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Assets | XXXXXX | ▲ XXXXXX | ▼ XXXXXX | ▼ -XXXXXXXX | ▲ XXXXXXX | ▲ 3.36M | ▲ 4.08M |
Total Non Current Assets | XXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▼ 3.72M | ▲ 4.29M |
Other Assets | X | X | X | X | X | ▲ 1.00 | ▼ 0.00 |
Total Assets | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 254.67M | ▲ 378.81M |
Account Payables | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ 1.51M | ▼ 862.00K |
Short Term Debt | X | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ 329.00K | ▼ 168.00K |
Tax Payables | XXXXXX | ▼ XXXXX | ▼ X | X | X | 0.00 | 0.00 |
Deferred Revenue | X | ▲ XXXXX | ▼ X | X | X | 0.00 | 0.00 |
Other Current Liabilities | XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ -XXXXXX | ▲ 9.71M | ▲ 10.04M |
Total Current Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ 11.55M | ▼ 11.07M |
Long Term Debt | X | ▲ XXXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ XXXXXX | ▼ 0.00 | 0.00 |
Deferred Revenue Non Current | X | X | X | X | X | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | X | X | X | X | X | 0.00 | 0.00 |
Other Non Current Liabilities | XXXXX | ▼ X | X | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Total Non Current Liabilities | XXXXX | ▲ XXXXXXX | ▼ XXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ 0.00 | 0.00 |
Other Liabilities | X | X | X | ▼ -XXXXXXX | ▲ X | 0.00 | 0.00 |
Capital Lease Obligations | X | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ 329.00K | ▼ 168.00K |
Total Liabilities | XXXXXXX | ▲ XXXXXXX | ▲ XXXXXXX | ▼ XXXXXXX | ▲ XXXXXXX | ▲ 11.55M | ▼ 11.07M |
Preferred Stock | X | X | X | ▲ XXXXXXXX | XXXXXXXX | ▼ 95.32M | 95.32M |
Common Stock | XXXX | ▲ XXXXX | ▲ XXXXX | ▼ XXXXX | ▲ XXXXX | ▲ 41.00K | ▲ 55.00K |
Retained Earnings | -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -XXXXXXXXX | ▼ -580.53M | ▼ -600.46M |
Accumulated Other Comprehensive Income Loss | -XXXX | ▲ X | X | ▼ -XXXXXXXX | ▲ -XXXXX | ▲ -41.00K | ▲ -14.00K |
Other Total Stockholders Equity | XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 728.33M | ▲ 872.83M |
Total Stockholders Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 243.12M | ▲ 367.74M |
Total Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 243.12M | ▲ 367.74M |
Total Liabilities And Stockholders Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 254.67M | ▲ 378.81M |
Minority Interest | X | X | X | X | X | 0.00 | 0.00 |
Total Liabilities And Total Equity | XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▲ XXXXXXXXX | ▲ 254.67M | ▲ 378.81M |
Total Investments | XXXXXXXX | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ XXXXXXXX | ▲ XXXXXXXXX | ▼ 71.00M | ▲ 197.90M |
Total Debt | X | ▲ XXXXXXX | ▼ XXXXXXX | ▼ XXXXXX | ▲ XXXXXX | ▼ 329.00K | ▼ 168.00K |
Net Debt | -XXXXXXXX | ▲ -XXXXXXX | ▼ -XXXXXXXX | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▼ -175.36M | ▲ -172.01M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -XXXXXXX | ▼ -XXXXXXX | ▲ X | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -31.41M | ▲ -19.93M |
Depreciation And Amortization | XXXX | ▼ X | X | X | X | 0.00 | 0.00 |
Deferred Income Tax | XXXXX | ▼ X | X | X | X | 0.00 | 0.00 |
Stock Based Compensation | XXXXXX | ▼ XXX | ▼ X | ▲ XXXXXX | ▲ XXXXXXX | ▲ 2.07M | ▲ 2.75M |
Change In Working Capital | -XXXXXXX | ▲ XXXXXX | ▼ X | ▲ XXXXXXX | ▲ XXXXXXX | ▼ -1.06M | ▼ -1.41M |
Accounts Receivables | X | X | X | X | X | 0.00 | 0.00 |
Inventory | X | X | X | X | X | 0.00 | 0.00 |
Accounts Payables | -XXXXXX | ▲ XXXXXX | ▼ X | ▲ XXXXXX | ▼ X | ▲ 375.00K | ▼ -651.00K |
Other Working Capital | -XXXXXX | ▲ XXXXXX | ▼ X | ▲ XXXXXX | ▲ XXXXXXX | ▼ -1.44M | ▲ -757.00K |
Other Non Cash Items | XXXXX | ▲ XXXXXX | ▼ X | ▲ XXXXXX | ▼ -XXXXXX | ▲ 163.00K | ▲ 2.89M |
Net Cash Provided By Operating Activities | -XXXXXXX | ▼ -XXXXXXX | ▲ X | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -30.24M | ▲ -19.09M |
Investments In Property Plant And Equipment | -XX | ▼ -XXXXX | ▲ X | X | ▼ -XXXXX | ▲ -16.00K | ▲ 0.00 |
Acquisitions Net | X | ▲ XXXXXXXX | ▼ X | ▼ -XXXXXXX | ▲ XXXXXX | ▲ 195.00K | ▼ 0.00 |
Purchases Of Investments | -XXXXXXXX | ▲ -XXXXXXXX | ▲ X | ▼ -XXXXXXXX | ▼ -XXXXXXXXX | ▼ -708.00M | ▼ -1.05B |
Sales Maturities Of Investments | XXXXXXXX | ▼ -XXXXXXXX | ▲ X | ▲ XXXXXXXX | ▲ XXXXXXXX | ▲ 706.00M | ▲ 923.00M |
Other Investing Activities | -XXXXX | ▲ XXXXX | ▼ X | ▲ XXXXXXX | ▼ -XXXXXX | ▲ -2.00K | ▼ -126.23K |
Net Cash Used For Investing Activities | -XXXXXXX | ▼ -XXXXXXXX | ▲ X | ▼ -XXXXXXXX | ▼ -XXXXXXXXX | ▲ -2.02M | ▼ -126.23M |
Debt Repayment | X | X | X | X | X | 0.00 | 0.00 |
Common Stock Issued | XXXXXXX | ▼ -XXXXXXXX | ▲ X | ▲ XXXXX | ▲ XXXXXXXXX | ▼ 87.98M | ▲ 141.81M |
Common Stock Repurchased | X | X | X | X | X | 0.00 | 0.00 |
Dividends Paid | X | X | X | ▼ -XXXXXXXX | ▲ X | 0.00 | 0.00 |
Other Financing Activities | XXXX | ▲ XXXXXXXX | ▼ X | ▲ XX | ▲ XXXXX | ▲ 87.98K | ▲ 141.81K |
Net Cash Used Provided By Financing Activities | XXXXXXX | ▼ XXXXX | ▼ X | ▲ XXXXX | ▲ XXXXXXXXX | ▼ 87.98M | ▲ 141.81M |
Effect Of Forex Changes On Cash | X | X | X | ▲ XXXXXXXX | ▼ X | 0.00 | 0.00 |
Net Change In Cash | -XXXXXXX | ▼ -XXXXXXXX | ▲ X | ▼ -XXXXXXXX | ▲ -XXXXXXXX | ▲ 55.72M | ▼ -3.52M |
Cash At End Of Period | XXXXXXXX | ▲ XXXXXXXX | ▼ X | ▲ XXXXXXXX | ▼ XXXXXXXX | ▲ 175.69M | ▼ 172.18M |
Cash At Beginning Of Period | XXXXXXXX | ▲ XXXXXXXX | ▼ X | ▲ XXXXXXXXX | ▼ XXXXXXXX | ▲ 119.97M | ▲ 175.69M |
Operating Cash Flow | -XXXXXXX | ▼ -XXXXXXX | ▲ X | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -30.24M | ▲ -19.09M |
Capital Expenditure | -XX | ▼ -XXXXX | ▲ X | X | ▼ -XXXXX | ▲ -16.00K | ▲ 0.00 |
Free Cash Flow | -XXXXXXX | ▼ -XXXXXXX | ▲ X | ▼ -XXXXXXX | ▼ -XXXXXXXX | ▼ -30.25M | ▲ -19.09M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Upgrade To Get Access
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Dicta eveniet ex illo maxime minima numquam quibusdam reprehenderit temporibus vel, voluptatum? Delectus eos eveniet id iusto necessitatibus, neque porro unde voluptatibus. Aut blanditiis commodi, iste iure laborum pariatur temporibus. Atque distinctio dolore, doloremque eaque eius harum inventore laudantium quibusdam recusandae voluptatibus.